Please provide your email address to receive an email when new articles are posted on . Pneumonia, hoarse voice and oral thrush were the greatest burdens with inhaled corticosteroids. Patients also ...

For years, the risks associated with the use of long-acting beta-agonists (LABAs) in patients with asthma have been uncertain, and some health care professionals have recommended conducting large ...

Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...

Please provide your email address to receive an email when new articles are posted on . Veterans using inhaled corticosteroids did not face increased odds for an asthma-related health care event after ...

Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.

Background and Goal: Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have ...

Benefit of inhaled corticosteroids for sinusitis small Review shows benefits of inhaled corticosteroids may be greater at higher doses and longer duration, but lower cost over-the-counter remedies may ...

The use of inhaled corticosteroids (ICS) during pregnancy may diminish the association between maternal asthma and reduced infant lung function and thus may improve respiratory health in infants born ...

Inhaled corticosteroids all share properties that make them effective topical antiinflammatory agents for treatment of asthma with minimal adverse systemic effects, particularly when administered in ...

The research is being presented at the Joint Congress of ESPE and ESE in Copenhagen Denmark, 10-13 May 2025. Individuals taking steroid tablets for more than 3 months are over 6 times more likely to ...

Asthma is an umbrella diagnosis covering a number of heterogeneous inflammatory pathways. In the past, excessive T-helper cell type 2 (Th2) response and immunoglobulin E (IgE) sensitivity were thought ...